Belantamab mafodotin - HY-P3239
Nur noch %1 verfügbar
Catalog #
HY-P3239
Ab
372,00 €
Belantamab mafodotin (GSK2857916) is composed of humanized and focused monoclonal antibody against B cell maturation antigen (BCMA) and McMMAF. The antibody portion is Belantamab (HY-P9980), and the drug-linker conjugate for ADC is McMMAF (HY-15578). Belantamab mafodotin has anti-myeloma activity[1][2].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-P3239/Belantamab-mafodotin-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Dry Ice |
| Application | Cancer-programmed cell death |
| Alternative Names | GSK2857916; Belantamab mafodotin-blm |
| CAS | 2050232-20-5 |
| Storage | -80°C, protect from light |
| MWT | 149000 (average) |
| Solubility | 10 mM in DMSO |
| Clinical Information | Launched |
| Target | Antibody-Drug Conjugates (ADCs) |
| Application: | Cancer-programmed cell death |
|---|